| 28 Apr, 09:14 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - General-Update | bse |
| 21 Apr, 08:23 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Orbicular s Partner secures tentative U.S. ANDA approval for a generic version of Ozempic® (Semaglutide Injection), supported by OneSource as CDMO partner". | nse |
| 21 Apr, 08:20 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Apr, 07:38 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation of "Renewal of EU-GMP Certification for OneSource : Flagship Unit II Facility'. | nse |
| 16 Apr, 10:16 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation of ESG Ratings received from NSE Sustainability Ratings & Analytics Limited | nse |
| 09 Apr, 08:06 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about allotment of ESOPs | nse |
| 02 Apr, 09:55 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 06 Mar, 07:03 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about General Update on Composite Scheme of Amalgamation (Merger by Absorption) amongst SteriscienceSpecialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides PharmaServices Private Limited and Onesource Specialty Pharma Limited and their respective shareholders - | nse |
| 05 Mar, 10:32 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about reaffirmation and withdrawal of credit ratings by CareEdge Ratings ( CARE ). | nse |
| 05 Mar, 10:30 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 26 Feb, 04:55 pm | — | … | Intimation regarding receipt of No Objection / No Adverse Observation Letter from The National Stock Exchange of India Limited / BSE Limited in relation to the draft composite scheme of arrangement and amalgamation (merger by absorption) amongst Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited and their respective shareholders (under section 230 to 232 read with section | nse |
| 12 Feb, 04:48 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about ESG rating by SES ESG Research Private Limited | nse |
| 12 Feb, 04:37 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 11 Feb, 08:22 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated February 11, 2026, "OneSource-Hikma partnership secures approval tocommercialise generic version of Ozempic® in Saudi Arabia". | nse |
| 11 Feb, 08:21 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Feb, 07:43 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.Promoter group entities have purchased additional 443,906 equity shares of OneSource Specialty Pharma Limited, between January 30, 2026 and February 04, 2026. | nse |
| 04 Feb, 05:55 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 04 Feb, 05:45 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 04 Feb, 05:43 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 03 Feb, 10:19 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 03 Feb, 10:17 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 30 Jan, 09:47 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Transcript of the Earnings Call | nse |
| 30 Jan, 09:42 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 28 Jan, 06:57 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 and Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.Promoter entity (Tenshi Pharmaceuticals Private Limited), has purchased 200,000 equity shares of OneSource Specialty Pharma Limited, from the market, on January 28, 2026.'. | nse |
| 28 Jan, 05:02 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 25 Jan, 02:48 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the unaudited financial results for the quarter ended December 31, 2025. | nse |
| 24 Jan, 02:15 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 24 Jan, 02:08 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Link of Recording | nse |
| 24 Jan, 02:04 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 24 Jan, 01:09 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about the addendum to the press release (original press release dated January 23, 2026). | nse |
| 24 Jan, 01:00 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 23 Jan, 09:31 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 23 Jan, 09:25 pm | — | … | Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 23 Jan, 09:19 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding Board meeting held on January 23, 2026 for approving the unaudited financial results for the quarter ended December 31,2025 | nse |
| 23 Jan, 08:45 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31, 2025 | bse |
| 21 Jan, 06:14 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Allotment of Equity shares under OneSource Employee Stock option plan -2021 | nse |
| 19 Jan, 03:54 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about schedule of the investor call to be held on Saturday, 24.01.2026 | nse |
| 19 Jan, 02:45 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025. | bse |
| 14 Jan, 04:50 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about intimation of Amalgamation of two wholly owned subsidiaries of the Company | nse |
| 14 Jan, 04:37 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Corporate Action-Amalgamation/ Merger / Demerger | bse |
| 09 Jan, 11:02 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | bse |
| 31 Dec, 07:34 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange regarding 'Intimation of Press Release done by the Credit Rating Agency'. | nse |
| 31 Dec, 07:15 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Intimation Of The Press Release Of Credit Rating Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 | bse |
| 23 Dec, 11:09 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 19 Dec, 10:44 am | — | … | Onesource Specialty Pharma Ltd - 544292 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 09 Dec, 04:18 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Allotment of ESOPS | nse |
| 18 Nov, 02:54 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about Transcript | nse |
| 18 Nov, 02:46 pm | — | … | Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Nov, 11:45 am | — | … | Onesource Specialty Pharma Limited has informed the Exchange about General Updates on Non-Participation of the representatives of the Company in Jefferies Conference | nse |
| 13 Nov, 07:44 pm | — | … | Onesource Specialty Pharma Limited has informed the Exchange about General Updates | nse |